{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:38:32Z","timestamp":1768927112573,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s10238-019-00605-3","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T14:03:17Z","timestamp":1582120997000},"page":"231-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Viral clearance ameliorates hematological and inflammatory markers among diabetic patients infected with hepatitis C genotype 4"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6909-8021","authenticated-orcid":false,"given":"A.","family":"Abdel Moneim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. A.","family":"Suleiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mabrouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Y.","family":"Zaky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,19]]},"reference":[{"key":"605_CR1","doi-asserted-by":"publisher","first-page":"2416281","DOI":"10.1155\/2017\/2416281","volume":"2017","author":"GU Rehman","year":"2017","unstructured":"Rehman GU, Ali M, Shah F, Iqbal A, Ahmad A, Hayat Z, et al. Prevalence of diabetes type 2 in hepatitis C infected patients in Kpk, Pakistan. Biomed Res Int. 2017;2017:2416281. https:\/\/doi.org\/10.1155\/2017\/2416281.","journal-title":"Biomed Res Int"},{"issue":"11","key":"605_CR2","first-page":"27","volume":"7","author":"A Abdel-Moneim","year":"2015","unstructured":"Abdel-Moneim A, Morsy BM, Abo-Seif MA, Zanaty MI. The effect of diabetes mellitus on the response to peginterferon-alpha in combination with ribavirin therapy in Egyptian chronic hepatitis C patients. Int J Pharm Pharm Sci. 2015;7(11):27\u201334.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"3","key":"605_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10238-019-00564-9","volume":"19","author":"HJ Jiang","year":"2019","unstructured":"Jiang HJ, Wang XX, Luo BF, Cong X, Jin Q, Qin H, et al. Direct antiviral agents upregulate natural killer cell potential activity in chronic hepatitis C patients. Clin Exp Med. 2019;19(3):299\u2013308.","journal-title":"Clin Exp Med"},{"key":"605_CR4","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3748\/wjg.v22.i4.1421","volume":"22","author":"R Gonz\u00e1lez-Grande","year":"2016","unstructured":"Gonz\u00e1lez-Grande R, Jim\u00e9nez-P\u00e9rez M, Gonz\u00e1lez Arjona C, Mostazo TJ. New approaches in the treatment of hepatitis C. World J Gastroenterol. 2016;22:1421\u201332.","journal-title":"World J Gastroenterol"},{"key":"605_CR5","doi-asserted-by":"publisher","first-page":"5260510","DOI":"10.1155\/2018\/5260510","volume":"2018","author":"N Okuroglu","year":"2018","unstructured":"Okuroglu N, Sertbas M, Ozdemir A. Treatment of chronic hepatitis C can improve glycemic control in patients with type 2 diabetes. Case Rep Hepatol. 2018;2018:5260510. https:\/\/doi.org\/10.1155\/2018\/5260510.","journal-title":"Case Rep Hepatol"},{"issue":"12","key":"605_CR6","doi-asserted-by":"publisher","first-page":"e0209216","DOI":"10.1371\/journal.pone.0209216","volume":"13","author":"A Gualerzi","year":"2018","unstructured":"Gualerzi A, Bellan M, Smirne C, Tran Minh M, Rigamonti C, Burlone ME, et al. Improvement of insulin sensitivity in diabetic and non-diabetic patients with chronic hepatitis C treated with direct antiviral agents. PLoS ONE. 2018;13(12):e0209216. https:\/\/doi.org\/10.1371\/journal.pone.0209216.","journal-title":"PLoS ONE"},{"key":"605_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","volume":"134","author":"R Moucari","year":"2008","unstructured":"Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology. 2008;134:416\u201323.","journal-title":"Gastroenterology"},{"issue":"1","key":"605_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2036.2007.03512.x","volume":"26","author":"BB Weksler","year":"2007","unstructured":"Weksler BB. Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease. Aliment Pharmacol Ther. 2007;26(1):13\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"605_CR9","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s12020-012-9662-7","volume":"43","author":"R Kawamoto","year":"2013","unstructured":"Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Abe M, et al. Hematological parameters are associated with metabolic syndrome in Japanese community-dwelling persons. Endocrine. 2013;43(2):334\u201341.","journal-title":"Endocrine"},{"key":"605_CR10","first-page":"185","volume":"5","author":"OA Dada","year":"2014","unstructured":"Dada OA, Uche E, Akinbami A, Odesanya M, John-Olabode S, Adediran A, et al. The relationship between red blood cell distribution width and blood pressure in patients with type 2 diabetes mellitus in Lagos, Nigeria. J Blood Med. 2014;5:185\u20139.","journal-title":"J Blood Med"},{"issue":"3","key":"605_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.aohep.2019.04.004","volume":"18","author":"SA Lozano-Sep\u00falveda","year":"2019","unstructured":"Lozano-Sep\u00falveda SA, Rinc\u00f3n-Sanchez AR, Rivas-Estilla AM. Antioxidants benefits in hepatitis C infection in the new DAAs era. Ann Hepatol. 2019;18(3):409\u2013536.","journal-title":"Ann Hepatol"},{"issue":"6","key":"605_CR12","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3109\/08820131003720710","volume":"39","author":"ME Zaki","year":"2010","unstructured":"Zaki ME, Saudy N, El Diasty A. Study of nitric oxide in patients with chronic hepatitis C genotype 4: relationship to viremia and response to antiviral therapy. Immunol Invest. 2010;39(6):598\u2013610.","journal-title":"Immunol Invest"},{"issue":"2","key":"605_CR13","doi-asserted-by":"publisher","first-page":"S285","DOI":"10.2337\/dc11-s239","volume":"34","author":"A Avogaro","year":"2011","unstructured":"Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care. 2011;34(2):S285\u2013S290290.","journal-title":"Diabetes Care"},{"issue":"4","key":"605_CR14","doi-asserted-by":"publisher","first-page":"e1003330","DOI":"10.1371\/journal.ppat.1003330","volume":"9","author":"AA Negash","year":"2013","unstructured":"Negash AA, Ramos HJ, Crochet N, Lau DTY, Doehle B, Papic N, et al. IL-1\u03b2 production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. 2013;9(4):e1003330. https:\/\/doi.org\/10.1371\/journal.ppat.1003330.","journal-title":"PLoS Pathog"},{"key":"605_CR15","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI25102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111\u20139.","journal-title":"J Clin Invest"},{"issue":"1","key":"605_CR16","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc14-S014","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association. Standards of medical care in diabetes\u20142014. Diabetes Care. 2014;37(1):S14\u2013S80.","journal-title":"Diabetes Care"},{"issue":"1","key":"605_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/gut.2010.236158","volume":"61","author":"AJ Thompson","year":"2012","unstructured":"Thompson AJ, Patel K, Chuang WL, Lawitz EJ, Rodriguez-Torres M, et al. Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2\/3. Gut. 2012;61(1):128\u201334.","journal-title":"Gut"},{"issue":"2","key":"605_CR18","first-page":"S26","volume":"36","author":"K Rife","year":"2019","unstructured":"Rife K, Lyman A, Le Clerc-Kamieniecki S, Falck-Ytter C, Pascuzzi K, Burant CJ, et al. Significant HbA1c lowering in patients achieving a hepatitis C virus cure. Fed Pract. 2019;36(2):S26\u2013S32.","journal-title":"Fed Pract"},{"issue":"1","key":"605_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/hep.20001","volume":"39","author":"J Choi","year":"2004","unstructured":"Choi J, Lee KJ, Zheng Y, Yamaga AK, Lai MM, Ou JH. Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology. 2004;39(1):81\u20139.","journal-title":"Hepatology"},{"issue":"5","key":"605_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/BF03401781","volume":"6","author":"R Zamora","year":"2000","unstructured":"Zamora R, Vodovotz Y, Billiar TR. Inducible nitric oxide synthase and inflammatory diseases. Mol Med. 2000;6(5):347\u201373.","journal-title":"Mol Med"},{"key":"605_CR21","first-page":"794","volume":"50","author":"C Pata","year":"2003","unstructured":"Pata C, Yazar A, Altintas E, Polat G, Aydin O, Tiftik N, et al. Serum levels of intercellular adhesion molecule-1 and nitric oxide in patients with chronic hepatitis related to hepatitis C virus: connection fibrosis. Hepatogastroenterology. 2003;50:794\u20137.","journal-title":"Hepatogastroenterology."},{"key":"605_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1155\/2002\/647961","volume":"18","author":"MI Hassan","year":"2002","unstructured":"Hassan MI, Kassim SK, Ali HS, el Sayed DA, Khalifa A. Evaluation of nitric oxide (NO) levels in hepatitis C virus (HCV) infection: relationship to schistosomiasis and liver cirrhosis among Egyptian patients. Dis Markers. 2002;18:137\u201342.","journal-title":"Dis Markers"},{"issue":"6","key":"605_CR23","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1002\/hep.22269","volume":"47","author":"MY Sheikh","year":"2008","unstructured":"Sheikh MY, Choi J, Qadri I, Friedman JE, Sanyal AJ. Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology. 2008;47(6):2127\u201333.","journal-title":"Hepatology"},{"issue":"1","key":"605_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.14715\/cmb\/2017.63.1.10","volume":"63","author":"O Ozcelik","year":"2017","unstructured":"Ozcelik O, Algul S. Nitric oxide levels in response to the patients with different stage of diabetes. Cell Mol Biol. 2017;63(1):49\u201352.","journal-title":"Cell Mol Biol"},{"key":"605_CR25","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1161\/01.ATV.0000248096.62495.73","volume":"26","author":"W Koenig","year":"2006","unstructured":"Koenig W, Khuseyinova N, Baumert J, Thorand B, Loewel H, Chambless L, et al. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA\/KORA Augsburg case-cohort study, 1984\u20132002. Arterioscler Thromb Vasc Biol. 2006;26:2745\u201351.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"605_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/ahg.12197","volume":"81","author":"NE Doody","year":"2017","unstructured":"Doody NE, Dowejko MM, Akam EC, Cox NJ, Bhatti JS, Singh P, et al. The role of TLR4, TNF-\u03b1 and IL-1\u03b2 in type 2 diabetes mellitus development within a North Indian population. Ann Hum Genet. 2017;81:141\u20136.","journal-title":"Ann Hum Genet"},{"key":"605_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.febslet.2007.11.057","volume":"582","author":"C de Luca","year":"2008","unstructured":"de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008;582:97\u2013105.","journal-title":"FEBS Lett"},{"issue":"2","key":"605_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-2004-832929","volume":"24","author":"SS Lee","year":"2004","unstructured":"Lee SS. Histological response to interferon alfa-based therapies in hepatitis C. Semin Liver Dis. 2004;24(2):55\u201360.","journal-title":"Semin Liver Dis"},{"key":"605_CR29","doi-asserted-by":"publisher","first-page":"e1003039","DOI":"10.1371\/journal.ppat.1003039","volume":"8","author":"HJ Ramos","year":"2012","unstructured":"Ramos HJ, Lanteri MC, Blahnik G, Negash A, Suthar MS, et al. IL-1\u03b2 signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog. 2012;8:e1003039.","journal-title":"PLoS Pathog"},{"key":"605_CR30","doi-asserted-by":"publisher","first-page":"8578051","DOI":"10.1155\/2018\/8578051","volume":"2018","author":"GN Saraiva","year":"2018","unstructured":"Saraiva GN, do Ros\u00e1rio NF, Medeiros T, Leite PEC, Lacerda GS, de Andrade TG, et al. Restoring inflammatory mediator balance after sofosbuvir-induced viral clearance in patients with chronic hepatitis C. Mediators Inflamm. 2018;2018:8578051. https:\/\/doi.org\/10.1155\/2018\/8578051.","journal-title":"Mediators Inflamm"},{"issue":"5","key":"605_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.9790\/487X-0654145","volume":"6","author":"M Asaduzzaman","year":"2017","unstructured":"Asaduzzaman M, Bappy SR, Fatema B, Haque S, Islam MJ, Sikder A, et al. Effect of hepatitis C virus (HCV) on hemoglobin, blood cells and random blood glucose levels among serologically positive HCV patients. IOSR-JNHS. 2017;6(5):41\u20135.","journal-title":"IOSR-JNHS"},{"key":"605_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/429290","author":"MH Tsai","year":"2015","unstructured":"Tsai MH, Lin KH, Lin KT, Hung CM, Cheng HS, Tyan YC, et al. Predictors for early identification of hepatitis C virus infection. BioMed Res Int. 2015. https:\/\/doi.org\/10.1155\/2015\/429290.","journal-title":"BioMed Res Int"},{"issue":"4","key":"605_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00018-009-0209-x","volume":"67","author":"C Flaujac","year":"2010","unstructured":"Flaujac C, Boukour S, Cramer-Bord\u00e9 E. Platelets and viruses: an ambivalent relationship. Cell Mol Life Sci. 2010;67(4):545\u201356.","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"605_CR34","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.3748\/wjg.v20.i10.2595","volume":"20","author":"H Hayashi","year":"2014","unstructured":"Hayashi H, Beppu T, Shirabe K, Maehara Y, Baba H. Management of thrombocytopenia due to liver cirrhosis: a review. World J Gastroenterol. 2014;20(10):2595\u2013605.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"605_CR35","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.15190\/d.2016.7","volume":"4","author":"GR Gabreanu","year":"2016","unstructured":"Gabreanu GR, Angelescu S. Erythrocyte membrane in type 2 diabetes mellitus. Discoveries. 2016;4(2):e60. https:\/\/doi.org\/10.15190\/d.2016.7.","journal-title":"Discoveries"},{"issue":"4","key":"605_CR36","first-page":"47","volume":"26","author":"A Abdel Moneim","year":"2019","unstructured":"Abdel Moneim A, Abdel-Reheim ES, Semmler M, Addaleel W. The impact of glycemic status and metformin administration on red blood cell indices and oxidative stress in type 2 diabetic patients. Malays J Med Sci. 2019;26(4):47\u201360.","journal-title":"Malays J Med Sci"},{"issue":"3","key":"605_CR37","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2337\/diabetes.52.3.581","volume":"52","author":"RP Robertson","year":"2003","unstructured":"Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes. 2003;52(3):581\u20137.","journal-title":"Diabetes"},{"issue":"1","key":"605_CR38","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.dsx.2018.12.016","volume":"13","author":"A Abdel-Moneim","year":"2019","unstructured":"Abdel-Moneim A, Mahmoud B, Sultan EA, Mahmoud R. Relationship of leukocytes, platelet indices and adipocytokines in metabolic syndrome patients. Diabetes Metab Syndr. 2019;13(1):874\u201380.","journal-title":"Diabetes Metab Syndr"},{"key":"605_CR39","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.jpeds.2015.01.017","volume":"166","author":"EA Osterholm","year":"2015","unstructured":"Osterholm EA, Georgieff MK. Chronic inflammation and iron metabolism. J Pediatr. 2015;166:1351\u20137.","journal-title":"J Pediatr"},{"key":"605_CR40","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/10408363.2014.992064","volume":"52","author":"GL Salvagno","year":"2015","unstructured":"Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 2015;52:86\u2013105.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"4","key":"605_CR41","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3109\/09537104.2015.1010441","volume":"26","author":"CN Jenne","year":"2015","unstructured":"Jenne CN, Kubes P. Platelets in inflammation and infection. Platelets. 2015;26(4):286\u201392.","journal-title":"Platelets"},{"issue":"1","key":"605_CR42","doi-asserted-by":"publisher","first-page":"e2017019","DOI":"10.4084\/MJHID.2017.019","volume":"9","author":"S Dahal","year":"2017","unstructured":"Dahal S, Upadhyay S, Banjade R, Dhakal P, Khanal N, Bhatt VR. Thrombocytopenia in patients with chronic hepatitis c virus infection. Mediterr J Hematol Infect Dis. 2017;9(1):e2017019. https:\/\/doi.org\/10.4084\/MJHID.2017.019.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"605_CR43","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.cell.2015.03.005","volume":"161","author":"LG Guidotti","year":"2015","unstructured":"Guidotti LG, Inverso D, Sironi L, Di Lucia P, Fioravanti J, Ganzer L, et al. Immunosurveillance of the liver by intravascular effector CD8(+) T cells. Cell. 2015;161:486\u2013500.","journal-title":"Cell"},{"key":"605_CR44","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijid.2016.02.025","volume":"45","author":"X Meng","year":"2016","unstructured":"Meng X, Wei G, Chang Q, Peng R, Shi G, Zheng P, et al. The platelet-to-lymphocyte ratio, superior to the neutrophil-to-lymphocyte ratio, correlates with hepatitis C virus infection. Int J Infect Dis. 2016;45:72\u20137.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"605_CR45","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1016\/j.dsx.2016.12.021","volume":"11","author":"C Mertoglu","year":"2017","unstructured":"Mertoglu C, Gunay M. Neutrophil\u2013lymphocyte ratio and platelet\u2013lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus. Diabetes Metab Syndr. 2017;11(1):S127\u2013S131131.","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"605_CR46","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10238-019-00561-y","volume":"19","author":"A Wr\u00f3blewska","year":"2019","unstructured":"Wr\u00f3blewska A, Lorenc B, Cheba M, Bielawski KP, Sikorska K. Neutrocyte-to-lymphocyte ratio predicts the presence of a replicative hepatitis C virus strand after therapy with direct-acting antivirals. Clin Exp Med. 2019;19(3):401\u20136.","journal-title":"Clin Exp Med"},{"issue":"9","key":"605_CR47","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1128\/JVI.77.9.5493-5498.2003","volume":"77","author":"H Zhu","year":"2003","unstructured":"Zhu H, Liu C. Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway. J Virol. 2003;77(9):5493\u20138.","journal-title":"J Virol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-019-00605-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-019-00605-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-019-00605-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T04:09:54Z","timestamp":1613707794000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-019-00605-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,19]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["605"],"URL":"https:\/\/doi.org\/10.1007\/s10238-019-00605-3","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,19]]},"assertion":[{"value":"24 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors of the manuscript declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}